TVGNW (Tevogen Inc. Warrant)
Insider Trading Activity
Every open-market purchase and sale reported by TVGNW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-17 | Neal Flomenberg | See Remarks | Sell | — | — |
| 2025-12-22 | Ryan H. Saadi | Chief Executive Officer | G | — | — |
| 2025-12-15 | Kirti Desai | Chief Financial Officer | G | — | — |
| 2025-12-12 | Ryan H. Saadi | Chief Executive Officer | G | — | — |
| 2025-08-18 | Ryan H. Saadi | Chief Executive Officer | G | — | — |
| 2025-07-01 | Ryan H. Saadi | Chief Executive Officer | A | — | — |
| 2025-07-01 | Sadiq Khan | Chief Commercial Officer | A | — | — |
| 2025-07-01 | Kirti Desai | Chief Financial Officer | A | — | — |
| 2025-07-01 | Neal Flomenberg | See Remarks | A | — | — |
| 2025-06-09 | Ryan H. Saadi | Chief Executive Officer | Sell | — | — |
| 2025-03-14 | Neal Flomenberg | See Remarks | Sell | — | — |
| 2025-03-11 | Neal Flomenberg | See Remarks | Sell | — | — |
| 2025-03-06 | Neal Flomenberg | See Remarks | Sell | — | — |
| 2024-12-26 | Keow Lin Goh | Director | A | — | — |
| 2024-12-26 | Curtis L. Patton | Director | A | — | — |
| 2024-12-26 | Victor J. Sordillo | Director | A | — | — |
| 2024-12-26 | SUSAN M PODLOGAR | Director | A | — | — |
| 2024-12-26 | Jeffrey L. Feike | Director | A | — | — |
| 2024-10-18 | Neal Flomenberg | See Remarks | Sell | — | — |
| 2024-06-13 | Kirti Desai | Chief Financial Officer | Buy | — | — |
| 2024-06-07 | Ryan H. Saadi | Chief Executive Officer | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Executive Officer | 124,478,377 | — |
| — | Chief Financial Officer | 10,149,186 | — |
| — | Director | 1,209,618 | — |
| — | Chief Commercial Officer | 1,169,618 | — |
| — | Director | 821,771 | — |
| — | Director | 433,923 | — |
| — | Director | 433,923 | — |
| — | Director | 336,962 | — |
| — | See Remarks | 77,893 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the TVGNW quote page; the site-wide leaderboard is on the insider transactions hub.